Search

Your search keyword '"Faivre-Finn, C"' showing total 432 results

Search Constraints

Start Over You searched for: Author "Faivre-Finn, C" Remove constraint Author: "Faivre-Finn, C" Database Unpaywall Remove constraint Database: Unpaywall
432 results on '"Faivre-Finn, C"'

Search Results

1. 77P Experience pooling control arms within a complex phase I drug-radiotherapy (RT) platform trial

2. OA06.03 An International EORTC Survey on Resectability of Stage III Non-small Cell Lung Cancer

4. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

5. P1.28-08 Definition of Resectable Stage III Non-Small Cell Lung Cancer: A Systematic Review from EORTC Lung Cancer Group

6. P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC

7. Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK

10. MO-0467 Impact of the COVID-19 pandemic on patient outcomes after curative-intent radiotherapy in the UK

14. OC-0608 Do patients with lung cancer and a genetic risk for rheumatoid arthritis have increased toxicity?

16. OC-0611 Lungtech EORTC 22113-08113 prospective multicenter trial: SBRT for central lung tumors.

20. Whole Tumor vs. FDG-Directed Dose Escalation in Patients with Locally Advanced NSCLC: Evaluation of Isotoxic Treatment Plans from the Randomized ARTFORCE PET-Boost Trial

21. Final Results of an International Delphi Consensus Study Regarding the Optimal Management of Radiation Pneumonitis

24. EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)

25. EP08.03-005 HALT - Targeted Therapy with or without Dose-Intensified Radiotherapy in Oligo-Progressive Disease in Oncogene Addicted Lung Tumours

26. EP05.01-012 Avoiding Cardiac Toxicity in Lung Cancer Radiotherapy (ACcoLade) Trial - Initial Results

27. Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study

32. OC-0437 Impact of introducing IMRT on curative intent radiotherapy and survival for lung cancer

38. PO-1877 Initial experience delivering stereotactic radiotherapy to a gluteal metastasis on a 1.5T MR Linac

41. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

42. Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial

44. 108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

49. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK

Catalog

Books, media, physical & digital resources